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Objective: Colposcopy can be used with Electrical Impedance 
Spectroscopy (EIS) as an adjunct, to assess the presence of High 
Grade Cervical Intra-epithelial Neoplasia (CIN2+). This analysis of 
longitudinal data has used the results from women with a negative 
colposcopy, in order to see if the initial (index) EIS results were able 
to predict the women who subsequently developed CIN2+. A 
further objective was to investigate what tissue structural changes 
might be reflected in the electrical impedance spectra.    
Methods: 847 patients were referred with low grade cytologly. EIS 
measurements were made around the transformation zone of the 
cervix during colposcopy. Every EIS spectrum was matched to a 
template representing CIN2+ and the result was positive if the 
match exceeded a probability index threshold. The colposcopic 
impression was also recorded. All the women who developed 
biopsy proven CIN2+ within three years of the index colposcopy 
were identified. 
Results: The median follow-up was 30.5 months. Where both CI and 
EIS were initially positive, there was an increased prevalence 
(8.13%) of CIN2+ developing as opposed to 3.45% in the remaining 
patients (p=0.0159). In addition, if three or more EIS spectra were 
positive there was a higher prevalence (9.62% as opposed to 3.56% 
p=0.0132) of CIN2+ at three years. The index spectra recorded from 
the women who developed CIN2+ showed EIS changes consistent 
with increases in the extracellular volume and in cell size 
inhomogeneity.  
Conclusion: EIS does offer prognostic information on the risk of 
CIN2+ developing over the three-year period following the EIS 
measurements. The changes in EIS spectra are consistent with an 
increase in cell size diversity as pre-malignancy develops. These 
changes may be a consequence of increased genetic diversity as 
neoplasia develops. 
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Colposcopy is widely used as part of screening programmes 
to detect cervical cancer and pre-cancer. The main objective 
of colposcopy is usually the detection of high-grade disease, 
defined as cervical intra-epithelial-neoplasia grade 2+ 
(CIN2+). There are a wide range of published diagnostic 
accuracy figures for clinical colposcopy. For example, 
Mitchell [1] in 1998 reported from 8 studies, as part of a 
meta-analysis, a weighted mean sensitivity of 85% and 
specificity 69%.  Underwood [2] in 2012 reported on 25 
studies and give pooled values of 91.3% for sensitivity and 
24.6% for specificity. Both Mitchell and Underwood reported 
a very wide variation in diagnostic accuracy figures. Brown 
and Tidy [3] in 2019 reviewed 18 publications that included 
sufficient raw data to enable comparative diagnostic 
accuracy figures to be calculated. They reported a weighted 
mean value of 75.1% for the sensitivity of colposcopy.  These 
figures for sensitivity suggest that there are a significant 
number of false negative results from colposcopy. The 
recent changes in many organised cervical screening 
programmes, such as the assessment of primary human 
papillomavirus (HPV), has increased the number of women 
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referred to colposcopy at very low risk of CIN2+. As a result, 
the poor performance of colposcopy is often a concern to 
colposcopists when discharging women from clinic after a 
negative colposcopy. The use of adjuncts in colposcopy, such 
as ZedScanTM has been shown to increase the detection of 
CIN2+ [4]. However, long term outcome data from women 
who have been discharged to community-based screening is 
lacking.  
This current investigation reports the results of a 
longitudinal service evaluation of patients who were 
negative at the initial (index) colposcopy but who, in some 
cases, were found to develop CIN2+ over the subsequent 
three years. The investigation also looked for any association 
between the index Electrical Impedance Spectroscopy (EIS) 
measurements and the subsequent development of disease.    
    
Methods 
Women who underwent an EIS examination using 
ZedScanTM, and had a negative colposcopic examination, 
were extracted from an on-going service evaluation of 
women referred for colposcopy during the period of 
December 2013 to August 2018. Women with a high-grade 
cytology referral were excluded. In addition, women 
referred following a previous colposcopy and women with 
clinical symptoms were excluded. Colposcopies were 
performed at the Jessop Wing Colposcopy Unit, Sheffield, 
UK. The cervical screening programme in Sheffield was one 
of six laboratories contributing to the NHS cervical screening 
evaluation of primary HPV screening (hrHPV) [5]. In every 
case the results of the index colposcopy examination were 
considered negative for the presence of high grade cervical 
intra-epithelial neoplasia (CIN2+), if the colposcopic 
impression (CI) was less than CIN2+ and if either, no biopsy 
was taken or, any biopsy taken was reported as CIN1 or less. 
Women with a CI of CIN2+ underwent biopsy. All the women 
were the subjects of a follow-up evaluation from the time of 
the index colposcopy. Women who developed biopsy proven 
CIN2+ within the three-year period were identified from the 
cytology, colposcopy and histopathology hospital databases.  
The outcomes measured included the subsequent 
prevalence of CIN2+ and, to allow for differences in the 
duration of follow-up between patients, the annual risk of 
developing CIN2+, expressed as a percentage risk. By using 
the actual time from the index colposcopy to the detection 
of disease in each woman this takes into account the fact 
that these times are not randomly or uniformly scattered 
within the three years. 
This was a service evaluation carried out in the Jessop 
Wing Colposcopy clinic and so no ethical approval was 
required [6]. All patient data was anonymised.  
The index colposcopy examination included the 
measurement of EIS as an adjunct to the examination. The 
outcome included both the Colposcopic Impression (CI) and 
the result of the EIS measurements. Since February 2013 the 
colposcopy unit has used EIS, as an adjunct to colposcopy to 
help increase detection of CIN2+4. EIS spectral 
measurements were made, using ZedScanTM, from a 
maximum of 12 points (minimum number was 9) around the 
transformation zone between the squamous and columnar 
cervical epithelia. Each measurement was of the complex 
transfer impedance between the pairs of current drive and 
receive electrodes that were on the tip of a hand-held probe, 
that was placed in contact with the tissue (see Fig 1). Only 
the real part of the complex impedances has been used in 
this analysis. The impedances were measured at 14 
frequencies, logarithmically spaced between 76 Hz and 625 
kHz. The disposable tip of ZedScanTM includes four AgCl 
electrodes of diameter 0.6 mm, with centres spaced around 
a circle of 2 mm diameter. This spacing of electrodes was 
chosen in order to be sensitive to tissue changes in cervical 
epithelium to a depth of about 400 µm. Several quality 
control checks are made on the measured impedance 
spectra before data is stored. 
 
 
Figure 1: The ZedScanTM handset, used to make the EIS 
measurements. The handset is shown placed on the base. The 
tapered disposable is shown on the left and terminates in the four 
AgCl electrodes that are placed on the tissue. The screen is used 
to guide the clinician to take up to 12 measurements around the 
transformation zone of the cervix. 
 
When used as an adjunct to colposcopy, ZedScanTM 
determines an index of probability that a measured 
spectrum corresponds to the presence of CIN2+. This index 
value is determined by calculating the match to a stored 
template that was determined from 3-D finite element, 
cellular-level, modelling of the structure of high grade CIN 
epithelium. This structure was determined by measure-
ments made from histopathology images of diseased tissue 
[7,8]. The calculated index of probability is used to guide the 
clinician in taking a diagnostic biopsy. In the current study an 
index threshold of 0.87, derived from previous studies for 
low grade referrals, was used for all the patients where the 
CI was negative. A lower threshold was applied where the CI 
was positive [4]. In every case the number of measured 
spectra that were above these thresholds was recorded, as 
occurring at either one, two or greater than two points. The 
outcome of the index EIS examination was recorded as 
positive if at least one of the twelve measured spectra was 
above the threshold. All the results were placed in one of 
four groups defined by both CI and EIS being negative, CI 
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being negative but EIS positive, both CI and EIS being positive 
or CI being positive but EIS negative.    
The measured spectra were also placed into two groups 
according to whether or not CIN2+ developed over the 
three-year follow-up period. The EIS spectra were then 
inspected to determine any significant differences between 
the two groups. Comparisons between the group means 
were made using an "N-1" Chi-squared test, as 
recommended by Campbell [9] and Richardson [10]. The 
Yates correction was used to allow for the small numbers in 
the groups. A Mann-Whitney non-parametric U test was also 
used to compare the groups.  
EIS spectra always fall with increasing frequency. The 
reason for this fall in impedance is that tissue consists of 
components with both electrically resistive and capacitive 
properties, determined by the presence of ions, some of 
which are bound in cell membranes and others free to move. 
If a potential is applied to tissue the capacitive components 
will store charge. When the potential is removed, the 
capacitors will discharge through the resistive components. 
Debye [11] showed that if this discharge is exponential then 
equations can be derived that show how impedance will fall 
with increasing frequency. If the Debye calculated spectra 
are compared with measurements from tissue it is found 
that the agreement between the theoretical and measured 
values is relatively poor. Cole and Cole [12] proposed a 
modification to the Debye equations that included a term 
Alpha. Values for Alpha can be used to give a good fit to 
measurements made on many tissues. The Cole equation 
can be written in terms of the resistive component of 
impedance (Z) as follows: 
In this equation R0 and R∞ are the resistances at zero and 
infinite frequency, respectively. F is the frequency of 
measurement. Fc is often referred to as the characteristic 
frequency. If a tissue, such as blood, is composed of a 
suspension of cells all of very similar size, then Fc increases 
as cell sizes decrease. It can also be shown that if the cell 
sizes are not homogeneous, but have a distribution of sizes, 
then α will increase. A population of cells is often referred to 
as a dispersion.  
A commonly used interpretation of the four Cole 
equation parameters for tissue is that the inverse of 
extracellular volume determines R0, the inverse of the total 
volume determines R∞, cell sizes determine Fc, which is the 
centre of the dispersion, and α is determined by the 
inhomogeneity of the cells within the dispersion. The Cole 
equation is an empirical equation that does not offer any 
quantitative figures that can be directly associated with 
tissue properties. The conductivity of the intracellular and 
extracellular spaces will also affect both R0 and R∞. See 
Grimnes and Martinsen for a discussion of the use of the Cole 
equation [13].  
In order to look for any changes in Fc or α, ideally the Cole 
equation should be fitted to every measured spectrum. 
Unfortunately, this was not possible because the individual 
spectra contained some noise and did not all show a clear 
dispersion, such as those shown in the mean spectra of Fig 
2. Two alternative approaches were used to look for changes 
in Fc and α. In the first, the slope of the spectrum between 
frequencies 1.22 and 2.44 kHz was determined, as a proxy 
for α. In the second, the Cole equation was fitted to the 
overall mean spectra for the two groups of women who 
either did or did not develop CIN2+. 
 
Ethical approval 
The research related to human use has been complied with 
all relevant national regulations, institutional policies and in 
accordance with the tenets of the Helsinki Declaration, and 
has been approved by the authors’ institutional review board 
or equivalent committee.  
 
Results 
847 women who met the evaluation criteria were identified. 
Of these, 579 women were referred with low grade 
abnormalities (Borderline nuclear change in squamous cells 
(ASCUS) or low grade dyskaryosis (LSIL)) and 268 women 
with persistent hrHPVpositive / cytology negative results.  
The median time of follow-up for all the patients, to the 
point where CIN2+ was identified, was 30.5 months. The 
patients were grouped as shown in Table 1. The median was 
35 months for Group 1, 34 months for Group 2 and 19 
months for Group 3. The prevalence of CIN2+ at 3 years for 
the evaluated population was 4.13% and the risk of 
developing CIN2+ at 3 years was 1.69% per annum (pa) over 
the follow-up period. The prevalence of CIN2+ and the risk 
of developing CIN2+ varied according to the outcome of the 
index colposcopic and ZedScan examinations (Table 1). 
 
 Outcome of 
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Table 1:  This shows how the 847 women were grouped for analysis. 
The prevalence of CIN2+, and the annual risk of disease, is also given 
for each group. The annual risk takes into account the fact that the 
first three groups of women did not have the same median period 
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The only one of the four groups that is significantly 
different from the other groups, in terms of the prevalence 
of CIN2+ arising in the three years following the index 
colposcopy, is group 3. Group 3 is associated with an 
increased prevalence (8.13%) of CIN2+ over the three years 
following the index colposcopy when compared with the 
other three groups combined (3.45%, p=0.0159). Group 3 is 
also associated with an increased prevalence when 
compared with groups 1 and 4 combined, where the EIS 
outcome was negative (3.2%, p=0.019). 
The EIS spectra were also inspected to see if the number 
of EIS positive spectra recorded in each woman was 
correlated with the prevalence of CIN2+. These figures were 
determined only for women where EIS was positive. The 
total number of women in this group is 441. The incidence of 
disease in these 441 women was broken down on the basis 
of the number of positive EIS spectra (Table 2). 
 
Number of 
abnormal EIS points 
Number of 
women 
Cases of CIN2+ 
within three years 
Prevalence 
of disease 
One 226 7 3.1% 
Two 111 5 4.50% 
Three or more 104 10 9.62% 
One or two 337 12 3.56% 
 
Table 2: The breakdown of the prevalence of disease in women 
where the index CI was negative and at least one EIS point was above 
the higher probability index threshold of 0.87. 
 
The group of 104 women where three or more spectra 
were above the probability index threshold, was significantly 
higher than in the remaining women (p= 0.0132). 
In order to compare the spectral shapes in women who 
either did or did not develop CIN2+ the overall median 
spectra for 31 women who did develop CIN2+ and 536 
women who did not develop CIN2+ over the three-year 
follow-up were determined. See Fig 2.  
 
 
Figure 2: This shows the median of all the 31 spectra where CIN2+ 
occurred in black with the 95% confidence levels shown in red. 
The median of all the 536 spectra where CIN2+ did not occur is 
also shown in black, but with the 95% confidence levels shown in 
blue. Log scales are used on both axes. 
 
The difference between the mean spectra is most 
marked at the lowest and highest frequencies. Application of 
an EIS cut-off of <800 Ohms at a frequency of 152 Hz 
identifies 16.6% (89/536) of the women in whom CIN2+ did 
not arise and 38.7% (12/31) in those where CIN2+ did arise. 
These figures correspond to a sensitivity of 38.7% and 
specificity of 83.4%. The results for the two groups at 152 Hz 
are statistically significantly different (p=0.0018). An ROC 
curve using the measured impedance at 152Hz is shown in 
Fig 3. The area under the curve (AUC) is 0.621. A Mann-
Whitney non-parametric U two-tailed test gives p=0.0088 
when comparing the AUC of the two patient groups.     
The differences between the two groups that did, or did 
not, develop CIN2+, at the lower EIS frequencies may be 
explained by a larger extracellular volume in the women who 
developed CIN2+. The changes at the highest frequencies 
may be the result of intracellular changes.  
The slope of the EIS spectra between frequencies 1.22 
and 2.44 kHz was used as a proxy for α. An ROC curve used 
to compare the groups who either did or did not develop 
CIN2+ gave an area-under-the-curve (AUC) of 0.596. This 
shows a weaker relation between the measured slope and 
the development of CIN2+. Selection of a cut-off of -0.080 to 
the data gives a sensitivity of 45.2% (95% CI 27.8-63.7) and 
specificity 70.1% (95% CI 66.0-74.0). 
 
 
Figure 3: An ROC curve comparing the EIS impedance of the two 
groups, at a frequency of 152 Hz, who either did or did not develop 
CIN2+. The AUC is 0.621, p=0.0088 when using a Mann-Whitney U 
test. 
 
The Cole equation parameters for the two mean spectra 
shown in Fig2 are given in Table 3. The Cole equation was 
fitted to the spectra using least-square minimisation. 
 
Women who did not 
develop CIN2+ 
 
Ro = 1485 R∞ = 80 Fc = 4500 α = 0.18 
Women who did 
develop CIN2+ 
Ro = 1220 R∞ = 90 Fc = 5100 α = 0.24 
 
Table 3: The Cole equation parameters of the curves shown in Fig 1. 
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It is not possible to put error figures to this data but it 
does appear that both Fc and α are increased in the women 
who develop CIN2+.    
Fig 4 shows the frequency differential of the two mean 
spectra shown in Fig 2. The points show the measured 
differentials, and the solid lines show the fitted Cole 
equations. It can be seen that the Cole equations fit the 
measured data quite well. It also shows the difference in the 
spectral shapes between the groups who did and did not 
develop CIN2+. The spectrum from the group who 
developed CIN2+ shows a smaller peak gradient and also a 
wider dispersion. This is consistent with an increase in α. 
 
 
Figure 4: Comparison of the frequency differential of the impedance 
spectra for the CIN2+ women (upper curve) and the <CIN2+ women 
(lower curve). The curves are from the fitted Cole equation. The 
parameters of the equation are given in Table 3.  
 
Discussion 
The main objective of this study was to use colposcopy and 
the associated EIS data collected over more than five years 
to see if the initial (index) results were able to identify any 
increased risk of CIN2+ developing over a three-year follow-
up.  All the women had a negative outcome following the 
index colposcopy. The results show that women where both 
the colposcopic impression (CI) and the EIS analysis were 
positive, even though no CIN2+ was identified, had an 
increased prevalence of CIN2+ over the subsequent three 
years. The prevalence was 8.13% as opposed to 3.45% in the 
remaining women. The risk of CIN2+ developing in the whole 
group was 4.13%. This figure is consistent with that reported 
by Kelly et al. [14], who reported on a follow-up of 965 
women, where it was found that 4.4% developed CIN2+ over 
a median time of follow-up of 27 months.  Cruickshank et al. 
[15], in a study of 884 women, recorded that 4.86% 
developed CIN2+ over a mean length of follow-up of 31 
months. They also showed that 8.58% of the women who 
were hrHPV positive, this group being similar to our group, 
developed CIN2+ with a risk of 3.3% pa. We have 
demonstrated in this study that, where colposcopy and EIS 
results were negative, both the prevalence and risk of 
developing CIN2+ are further reduced (3.28% and 1.20% pa). 
EIS, when used as an adjunct to colposcopy, identifies 
points on the cervix where the EIS spectrum is consistent 
with the presence of CIN2+. This information is used to guide 
the clinician as to where best to take a biopsy. In this study 
we compared the incidence of disease in women where 
three or more points were identified as opposed to fewer 
such points. It was found that the women where three or 
more points were identified had a higher incidence of CIN2+ 
(9.62%) over the subsequent three years. This result is 
consistent with EIS identifying an increased spatial spread of 
pre-malignant changes in these women.   
The EIS data was also analysed in isolation to see if this 
was able to identify the increased risk of CIN2+ developing. 
It was found that the group of women who developed CIN2+ 
had a significantly lower impedance at the lower EIS 
frequencies (p=0.0088). There also appeared to be changes 
in the shape of the EIS spectra in the EIS frequencies around 
1-10 kHz. The characteristic frequency and width of the 
dispersion appeared to be changed. These changes may be 
interpreted as arising from increases in both extracellular 
volume and tissue inhomogeneity in the women who 
developed CIN2+.  
A weakness of this study is that, whilst the data is taken 
from a relatively large group of women, the numbers who 
developed CIN2+ are quite small. The results do reach 
statistical significance but should none-the-less be looked at 
critically in future research.    
It is interesting to speculate as to the reasons why the 
changes we observed in the EIS spectra were associated with 
an increased risk of CIN2+ in some women. Can a prognostic 
value, based upon EIS, be explained in terms of an increased 
diversity of cellular structures? Increased diversity of cell 
sizes, and shapes should increase the dispersion in an EIS 
spectrum and will also change the architecture of the 
extracellular space. A homogeneous cell population can be 
closely packed with a relatively low extracellular volume. 
However, if cells are less homogeneous in size then they 
cannot be closely packed and extracellular volume will be 
larger. Possibly the genetic diversity of pre-cancer cells is 
giving rise to EIS changes, and the presence of these changes 
over several sites around the transformation zone, is 
evidence of this increased diversity? These changes would 
not be apparent when screening cytology or histopatho-
logical examination of biopsied epithelia are being assessed. 
Wilson [16] pointed out a number of publications 
reporting the genetic diversity associated with the 
progression of bladder cancer [17] and Barrett’s oesophagus 
[18]. Maley et al. [19] reviews the evolutionary features of 
neoplasms. Multiple biopsy samples from neoplasms in one 
individual show a very wide genetic diversity. It is possible 
that gene expression then leads to an increasing 
inhomogeneity of cell structures as cancers evolve.  
The main conclusion of this study is that EIS does appear 
to contain prognostic information on evolving cervical 
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neoplasia. This should be useful in patient management 
following a negative colposcopy. This management would be 
different for the patient groups shown in Table 1. If both 
colposcopy and EIS are negative, then these women are at a 
very low risk of developing CIN2+ at three years. However, if 
EIS changes are present then these can be used to assess any 
increased future risk. A further significant conclusion is that 
the changes in EIS spectra in women who develop high grade 
CIN are consistent with an increase in the diversity of cell 
sizes and extracellular volume in the epithelium. This may be 
a consequence of increasing cellular diversity as cancer 
evolves. 
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